Back to results
US 12,642,876 B1Granted
Cholecystokinin-2 receptor targeted compounds and use thereof
AssigneePerspective Therapeutics, Inc.
InventorsDijie Liu, Mengshi Li, Nicholas Baumhover, M M Hasibuzzaman, Dulanjali Thennakoon, Zhiming Dai, Michael K. Schultz
Life of this patent
Estimating the term…
Abstract
The present disclosure provides, inter alia, novel compounds targeting cholecystokinin-2 receptor (CCK2R) expressed on the surface of cancer cells. Also provided are methods for imaging, diagnosing, and/or treating cancers using the same.
Claims9
A peptidomimetic conjugate having a structure selected from one of the following:
Dependencies are inferred from the claim text.